From: Psychiatric disorders, personality and neuropsychological alterations in Erdheim-Chester disease
n (%) | |
---|---|
BRAF V600E mutation | 20 (62.5) |
Age at first symptoms (mean[SD]) | 49.6 [14.2] |
Current treatment | |
Steroid | 6 (18.8) |
Interferon alpha | 2 (6.3) |
Vemurafenib | 12 (37.5) |
Cobimetinib | 4 (12.5) |
Others | 5 (15.6) |
Past treatment | |
Steroid | 13 (40.6) |
Interferon alpha | 24 (75) |
Vemurafenib | 12 (37.5) |
Cobimetinib | 7 (21.9) |
Others | 13 (40.6) |
Cerebral MRI patterns* | |
MRI considered as normal | 8 (25) |
Tumoral patterns | 19 (59.4) |
Pseudo-degenerative patterns | 15 (46.9) |
Vascular patterns | 7 (21.9) |